NC Emerge® H7493926720600Recalls & reported problems
Boston Scientific Corporation · PTCA Dilatation Catheter · Class 2
All models of NC Emerge (61)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08714729846734), received between Oct 27, 2022 and Apr 18, 2025 — classified as 2 injuries, 1 malfunction.
The most frequently reported specific device problem is “Break” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Break3
- Difficult to Remove2
- Detachment of Device or Device Component1
- Failure to Deflate1
- Material Integrity Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 18, 2025Break; Difficult to Remove; Break; Difficult to Remove
IT WAS REPORTED VIA MEDWATCH (B)(4) THAT SHAFT BREAK AND REMOVAL DIFFICULTY OCCURRED. THE TARGET LESION WAS LOCATED IN THE LEFT RENAL ARTERY. A 6.00MM X 20MM NC EMERGE BALLOON CATHETER WAS ADVANCED FOR DILATION OF EXISTING STENT. WHEN ATTEMPTING TO DEFLATE AND REMOVE THE BALLOON, THE CATHETER SHAFT BROKE WITH THE BALLOON PARTIALLY INFLATED MAKING IT DIFFICULT TO REMOVE. SIGNIFICANT BUNCHING OF THE CATHETER WAS IDENTIFIED WHEN THE BALLOON CATHETER WAS INSPECTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21868292 ↗InjuryMar 26, 2025Break; Difficult to Remove; Detachment of Device or Device Component; Material Integrity Problem; Failure to Deflate; Break; Difficult to Remove; Detachment of Device or Device Component; Material Integrity Problem; Failure to Deflate
IT WAS REPORTED THAT BALLOON DETACHMENT OCCURRED. THE PATIENT PRESENTED FOR ABDOMINAL AORTIC ANEURYSM REPAIR WITH A FENESTRATED GRAFT. THE 6.00 MM X 20 MM NC EMERGE BALLOON CATHETER WAS ADVANCED TO DILATE AN EXISTING LEFT RENAL STENT. DURING AN ATTEMPT TO DEFLATE AND REMOVE THE BALLOON, THE CATHETER SHAFT BROKE WITH THE BALLOON STILL PARTIALLY DEFLATED. EXTENSIVE WORK AND TIME, PLUS AN ADDITIONAL VASCULAR SURGERY PHYSICIAN WERE REQUIRED TO REMOVE THE FRAYED CATHETER AND UNFURLED BALLOON. THE PROCEDURE WAS ABORTED. THORACIC AND PARA-VISCERAL ANGIOGRAM DELINEATED NO EVIDENCE OF OVERT AORTIC INJURY AND NO EVIDENCE OF A TYPE 1A ENDO LEAK. THE PATIENT WAS TAKEN TO THE INTENSIVE CARE UNIT IN STABLE CONDITION AND WAS SCHEDULED FOR AN OPEN SURGICAL REPAIR OF THEIR AORTIC ANEURYSM. WHEN THE BALLOON CATHETER WAS INSPECTED, SIGNIFICANCE BUNCHING OF THE CATHETER WAS IDENTIFIED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21697643 ↗InjuryOct 27, 2022Break; Break
IT WAS REPORTED THAT A SHAFT BREAK OCCURRED REQUIRING ADDITIONAL INTERVENTION. DURING A PERCUTANEOUS CORONARY INTERVENTION (PCI) PROCEDURE, A 6.00MM X 20MM NC EMERGE BALLOON CATHETER WAS ADVANCED FOR DILATATION. HOWEVER, DURING REMOVAL, IT WAS NOTED THAT THE HYPOTUBE PORTION WAS MISSING AND IT WAS FOUND IN THE GUIDE. THE MISSING PIECE OF THE DEVICE WAS REMOVED BY SNARING. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15683165 ↗
Other Catheters, transluminal coronary angioplasty, percutaneous devices
- MINI TREK™ 1012270-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous223 reports
- Maverick²™ H7493892815200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous1 death203 reports
- MINI TREK™ 1012270-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous162 reports
- Maverick²™ H7493892820200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous161 reports
- NC TREK 1012454-08Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 recalls59 reports
- TREK™ 1012272-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 deaths158 reports
- NC TREK 1012453-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall84 reports
- NC TREK 1012453-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall1 death83 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page